WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 1-Jun.-2018 (data as of 25-May-2018)
Next overall update Mid-July 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1'3301 Infant (under 12 months) mortality rate: 532
GDP / capita (US$): 3'1231 Child (under 5 years) mortality rate: 802

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 24'054  23'439  22'835  22'240  21'656  15'274  11'715  8'618 
Births 861  852  842  832  822  633  524  398 
Surviving infants 810  800  789  778  767  572  473  357 
Pop. less than 5 years 3'861  3'804  3'742  3'679  3'617  2'612  2'186  1'582 
Pop. less than 15 years 10'277  10'056  9'827  9'605  9'377  6'868  5'426  3'848 
Female 15-49 years 5'743  5'579  5'422  5'265  5'114  3'448  2'527  1'900 

Number of reported cases

(Click for retrospective incidence data for Cameroon)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  712  338  1'809  831  760  14'629  21'150 
Mumps
ChartChart
 
Pertussis
ChartChart
  5'498 
Polio*
ChartChart
  38  255 
Rubella
ChartChart
  711  13  277  147  148 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  51  58  26  33  43  279  382 
Tetanus (total)**
ChartChart
  51  58  120  110  43  279  382 
Yellow fever
ChartChart
  61  15  173 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Cameroon)
Vaccine year result method % card seen                                                
BCG 2013  92  MICS   67  91  70  74  82  82  69  52 
DTP1 2013  89  MICS   67  93  92  92  93  95  54 
DTP3 2013  82  MICS   67  86  85  84  87  89  53  36 
DTP4         
IPV1          76  79  31 
HepB_BD         
HepB3 2013  82  MICS   67  86  85  84  87  89 
Hib3 2013  82  MICS   67  86  85  84  87  89 
JapEnc         
MCV1          77  78  79  80  83  49  36 
MCV2         
MenA         
PCV1          92  92  90  93  95 
PCV2          86  86  84  88  88 
PCV3 2013  81  MICS   67  84  84  85  87  88 
Pol3 2013  87  MICS   67  84  83  83  86  88  49  34 
Rota1          89  87  81  58 
RotaC          83  80  73  46 
RCV1          77 
TT2plus 2010  59  DHS   57  72  59  62  64  68  40  12 
PAB         
VAD1          55  51  43  65  86 
YFV 2013  85  MICS   67  78  78  77  80  83 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Cameroon)
BCG
ChartChart
  74  74  82  82  78  76 
DTP1
ChartChart
  92  92  93  95  66  70 
DTP3
ChartChart
  84  84  87  89  62  48 
HepB3
ChartChart
  84  84  87  89 
HepB_BD
 
Hib3
ChartChart
  84  84  87  89 
IPV1
  31  31 
MCV1
ChartChart
  79  79  80  83  49  56 
MCV2
 
PCV3
ChartChart
  85  85  87  88 
Pol3
ChartChart
  83  83  86  88  57  54 
RCV1
 
RotaC
ChartChart
  73  73  46 
YFV
ChartChart
  77  77  80  83 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 189  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 45
From 80 to 89% 26
From 50 to 79% 26
Less than 50% 2
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB_Pediatric birth; Yes From 2019
HPV girls 9-14 years; Yes From 2019
IPV 14 weeks; Yes
MenA 15 months; Yes From 2019
MR 9 months; Yes 2nd dose at 15 months planned from December 2018
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
Td 1st contact; +1, +6 months; Yes Pregnant women
TT 1st contact; +1, +6 months; +1, +1 years; Yes Pregnant women
VitaminA 6, 12, 18, 24, 30, 36 months; Yes 6-59 months and postpartum
YF 9 months; Yes 0-11 months

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2015-2019  2015-2019  2015-2019  2011-2015  2011-2015  2011-2015  2011-2015 
Nº of districts with microplans that include activities to raise immunization coverage number 55  189  189  187  180  169  179 

System performance

Total Nº districts in country number 189  189  189  187  181  181  179 
Nº districts with DTP3 coverage >=80% number 135  119  128  133  142  135  118 
% of districts with DTP3 coverage >=80% From 0 to 100% 71  63  68  71  78  75  66 
Nº districts with measles (MCV1) coverage >=95% number 30  36  31  32  44  51  33 
% of districts with MCV1 coverage >=95% From 0 to 100% 16  19  16  17  24  28  18 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 32  33  10  21  16  13  24 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  No  No  No  No  NA 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2018
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.